Needham & Company
Needham & Company Remains Bullish on Argos Therapeutics (ARGS) Following Interim Analysis of AGS-003
-
Needham & Company Reiterates Buy on Argos Therapeutics (ARGS) Following ESMO Meeting
-
Needham & Company Highlights Three Under-the-Radar Biotech Stocks (ARGS) (TLOG) (CYTK)
-
Argos Therapeutics to Present at the 14th Annual Needham Healthcare Conference
-
Argos Therapeutics to Present at the 14th Annual Needham Healthcare Conference
-
Argos Therapeutics to Present at the 13th Annual Needham Healthcare Conference
-
Needham & Company Starts Argos Therapeutics (ARGS) at Buy
-
Argos Therapeutics (ARGS) IPO Opens, Trades Solidly Higher
-
Argos Therapeutics (ARGS) Files $60M IPO
-
Argos Therapeutics (ARGS) Files $86.25M IPO

